Replies to post #319241 on Bioelectronics Corp (BIEL)

[Probity]

For answers to the first batch of questions, well, I can’t seem to find my Crystal Ball. Maybe I’ll call 1.800.Nostradamus, and also check with a fortune teller for a second opinion. If you do know the answers, do share so we can avoid a roundabout to no where.

The second batch of comments can likely best be addressed for you by contacting the Voices for Non-Opioid Choices organization. There are many members of the coalition under their umbrella posted there originating from the Federal, State, and Local levels that have expressed support for the Act, and both sources might be of interest and clarification for you.

I imagine, at the minimum, that members of the coalition see a two-fold benefit once the Act and CMS insurance reimbursement commences….

Less opioid use so less addictions and deaths stressing the health care system, individuals at risk, their families, and all done with immense cost savings via better health care.

Secondly, treatments that work, whether wholly or in an adjunctive capacity, offering safe, non-addictive, lawsuit-avoiding alternatives that would be monetarily attractive choices given CMS placing non-opioid treatments monetarily ON PAR with other separately paid drugs.

We’ll see if BIEL and its products become part of that process either wholly in some cases, or in an adjunctive capacity in others.

All imo.